ArticleCancers2018

miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma.

Bernhard Ralla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.